Biomaterials, Год журнала: 2024, Номер 316, С. 123001 - 123001
Опубликована: Дек. 6, 2024
Язык: Английский
Biomaterials, Год журнала: 2024, Номер 316, С. 123001 - 123001
Опубликована: Дек. 6, 2024
Язык: Английский
Archives of Biochemistry and Biophysics, Год журнала: 2025, Номер 768, С. 110385 - 110385
Опубликована: Март 12, 2025
Язык: Английский
Процитировано
0Phytomedicine, Год журнала: 2025, Номер unknown, С. 156767 - 156767
Опубликована: Апрель 1, 2025
Язык: Английский
Процитировано
0Advanced Science, Год журнала: 2024, Номер unknown
Опубликована: Сен. 18, 2024
Abstract Spinal cord injury (SCI) is a severe to the central nervous system, and its treatment always major medical challenge. Proinflammatory cell death considered an important factor affecting neuroinflammation prognosis after injury. PANoptosis, newly discovered type of proinflammatory death, regulates activation executioner molecules apoptosis, pyroptosis necroptosis through PANoptosome, providing new target for therapeutic intervention SCI. However, role regulatory mechanism in SCI are not yet elucidated. Here, based on proteomic data, YBX1 expression significantly increased neurons Guided by RIP‐seq, subsequent experiments reveal that promotes ZBP1 stabilizing Zbp1 mRNA, thereby aggravating ZBP1‐mediated PANoptosis. Furthermore, E3 ubiquitin ligase TRIM56 identified as endogenous inhibitor via molecular docking IP/MS analysis. Mechanistically, bound promoted ubiquitination, accelerating degradation. Taken together, these findings novel function regulating PANoptosis pathogenesis verified functions promote ubiquitin‐proteasomal degradation YBX1, insights into strategies.
Язык: Английский
Процитировано
3Experimental and Molecular Pathology, Год журнала: 2024, Номер 140, С. 104944 - 104944
Опубликована: Ноя. 21, 2024
Язык: Английский
Процитировано
3International Journal of Medical Sciences, Год журнала: 2024, Номер 21(13), С. 2464 - 2479
Опубликована: Янв. 1, 2024
MAPKK4 has been implicated in the pathological mechanisms underlying myocardial and vascular injury, specifically influencing endothelial cell damage programmed death via subcellular pathways. Nevertheless, regulatory role of coronary microvascular injury following infarction remains unconfirmed, exploration targeted mitochondrial protective therapeutic agents unaddressed. In light this gap, we established a gene-modified mouse model ischemia-reperfusion employed Buyang Huanwu decoction (BYHW), traditional cardiovascular formula, to assess its efficacy treating post-ischemia-reperfusion. The study aimed elucidate mechanism by which BYHW mitigates induced through attenuation apoptosis. Experimental outcomes revealed that high-dose significantly ameliorated post-ischemia-reperfusion, restoring structural integrity microvasculature reducing inflammation oxidative stress. Contrarily, transgenic mice overexpressing MAPKK4, intervention failed attenuate To further investigate, simulated hypoxia/reoxygenation cells using MAPKK4-related cellular gene modification model. results indicated attenuates inflammatory enhances viability hypoxic stress, inhibiting apoptosis pathway. However, overexpression MAPKK4/p38 negated effects BYHW, showing no impact on stress under conditions. Molecular interaction studies confirmed active components Astragaloside IV Ligustrazine, interact with MAPKK4/P38 axis.
Язык: Английский
Процитировано
1Biomaterials, Год журнала: 2024, Номер 316, С. 123001 - 123001
Опубликована: Дек. 6, 2024
Язык: Английский
Процитировано
0